Fulcher G., Singer J., Castañeda R., Fraige Filho F., Maffei L., Snyman J., Brod M.
Northern Clinical School, E25 - Royal North Shore Hospital, University of Sydney, St Leonards, Sydney, NSW, Australia; Endocrine Institute, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; Clinical Epidemiology Research Unit, Hospital General Regional No 1 Dr Carlos Mac Gregor Sánchez Navarro, Mexico City, Mexico; Faculdade de Medicina, Fundação Do ABC, Sao Paulo, Brazil; Consultorios Asociados de Endocrinología e Investigación Clínica Aplicada, Buenos Aires, Argentina; Agility Global Health Solutions, Centurion, South Africa; Brod Group, Mill Valley, CA, United States
Fulcher, G., Northern Clinical School, E25 - Royal North Shore Hospital, University of Sydney, St Leonards, Sydney, NSW, Australia; Singer, J., Endocrine Institute, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel; Castañeda, R., Clinical Epidemiology Research Unit, Hospital General Regional No 1 Dr Carlos Mac Gregor Sánchez Navarro, Mexico City, Mexico; Fraige Filho, F., Faculdade de Medicina, Fundação Do ABC, Sao Paulo, Brazil; Maffei, L., Consultorios Asociados de Endocrinología e Investigación Clínica Aplicada, Buenos Aires, Argentina; Snyman, J., Agility Global Health Solutions, Centurion, South Africa; Brod, M., Brod Group, Mill Valley, CA, United States
Objectives: To understand the impact of nocturnal and daytime non-severe hypoglycemic events on healthcare systems, work productivity and quality of life in people with type 1 or type 2 diabetes.Methods: People with diabetes who experienced a non-severe hypoglycemic event in the 4 weeks prior to the survey were eligible to participate in a nocturnal and/or daytime hypoglycemia survey. Surveys were conducted in Argentina, Australia, Brazil, Israel, Mexico and South Africa.Results: In total, 300 respondents were included in nocturnal/daytime hypoglycemia surveys (50/participating country/survey). All respondents with type 1 diabetes and 68%/62% (nocturnal/daytime) with type 2 diabetes were on insulin treatment. After an event, 25%/30% (nocturnal/daytime) of respondents decreased their insulin dose and 39%/36% (nocturnal/daytime) contacted a healthcare professional. In the week after an event, respondents performed an average of 5.6/6.4 (nocturnal/daytime) additional blood glucose tests. Almost half of the respondents (44%) reported that the event had a high impact on the quality of their sleep. Among nocturnal survey respondents working for pay, 29% went to work late, 16% left work early and 12% reported missing one or more full work days due to the surveyed event. In addition, 50%/39% (nocturnal/daytime) indicated that the event had a high impact on their fear of future hypoglycemia.Conclusions: The findings suggest that nocturnal and daytime non-severe hypoglycemic events have a large financial and psychosocial impact. Diabetes management that minimizes hypoglycemia while maintaining good glycemic control may positively impact upon the psychological wellbeing of people with diabetes, as well as reducing healthcare costs and increasing work productivity. © 2014 Informa UK Ltd.
antidiabetic agent; glucose; insulin; antidiabetic agent; glucose blood level; adult; Argentina; Article; Australia; Brazil; daytime hypoglycemia; daytime hypoglycemia; diabetic patient; drug dose reduction; fear; female; glucose blood level; health care personnel; health economics; health impact assessment; health survey; human; hypoglycemia; insulin dependent diabetes mellitus; insulin treatment; Israel; major clinical study; male; Mexico; nocturnal hypoglycemia; non insulin dependent diabetes mellitus; productivity; quality of life; salary; sleep quality; social psychology; South Africa; working time; chemically induced; diabetes mellitus; economics; hypoglycemia; middle aged; psychology; Adult; Blood Glucose; Diabetes Mellitus; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Quality of Life